OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Diverticular Perforation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,048 reports · 49 co-occurring drugs

As of the last recalculation, Diverticular Perforation appears in 2,048 FAERS reports alongside 49 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 19.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Baricitinib1819.119.2
Thalidomide4613.013.0
Tocilizumab12912.212.2
Gentamicin1410.911.0
Metronidazole6510.610.7
Metronidazole Topical4710.210.2
Naproxen Sodium Tablet, Coated139.89.8
Naproxen Sodium, Coated Tablets139.89.8
Naproxen Sodium 220Mg139.89.8
Gentamicin Sulfate149.19.1
Ketoprofen118.68.6
Daratumumab338.58.5
Sorafenib178.48.4
Pemetrexed Disodium308.18.1
Bortezomib698.18.1
Bevacizumab917.87.8
Temozolomide157.37.3
Dexamethasone Sodium Phosphate77.07.0
Daptomycin66.66.6
Olmesartan Medoxomil236.66.6
Lenvatinib206.26.3
Tofacitinib Citrate86.26.2
Piperacillin Sodium,Tazobactam Sodium166.26.2
Dexamethasone 1.5 Mg1646.16.1
Dexamethasone1646.06.0
Sunitinib Malate225.75.7
Gefitinib55.65.6
Nintedanib165.25.2
Carboplatin625.15.1
Pitavastatin Calcium55.05.0
Norepinephrine54.84.8
Cisplatin364.74.8
Golimumab394.74.7
Remdesivir64.64.6
Azacitidine For84.54.5
Sevelamer Carbonate54.44.4
Agalsidase Beta44.44.4
Bendamustine Hydrochloride54.34.3
Cetuximab134.24.2
Vemurafenib54.24.2
Polatuzumab Vedotin44.24.2
Azacitidine124.14.1
Axicabtagene Ciloleucel44.14.1
Upadacitinib303.83.8
Atezolizumab143.73.7
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride103.33.3
Lenalidomide1012.52.5
Sarilumab62.32.3
Guselkumab82.32.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.